Literature DB >> 17655493

Transduction of rhesus macaque hematopoietic stem and progenitor cells with avian sarcoma and leukosis virus vectors.

Jingqiong Hu1, Andrea Ferris, Andre Larochelle, Allen E Krouse, Mark E Metzger, Robert E Donahue, Stephen H Hughes, Cynthia E Dunbar.   

Abstract

Genome-wide integration site analyses showed that Moloney murine leukemia virus (MoMLV)- and lentivirus-derived vectors integrate preferentially into the coding regions of genes, posing a risk of insertional mutagenesis. Avian sarcoma and leukosis viruses (ASLVs) were previously reported to have a weak preference for gene-coding regions in a cell line study as compared with human immunodeficiency virus and MoMLV; however, thus far these vectors have not been studied for their potential efficacy in transduction of hematopoietic progenitor and stem cells. In this study we investigated for the first time the ability of ASLV-derived RCAS (replication-competent ALV LTR [avian leukosis virus long terminal repeat] with a splice acceptor) vectors to transduce rhesus macaque hematopoietic progenitors and long-term repopulating cells, in an autologous transplantation model. RCAS vectors can efficiently and stably transduce rhesus macaque CD34+ hematopoietic progenitor cells with an efficiency of transduction of up to 34% ex vivo. In two animals transplanted with RCAS vector-transduced autologous CD34+ cells, highly polyclonal hematopoietic reconstitution with sustained gene-marking levels in myeloid and lymphoid lineages was observed up to 18 months post-transplantation. These findings are encouraging and suggest that this vector system should be explored and further optimized for gene therapy applications targeting hematopoietic stem and progenitor cells.

Entities:  

Mesh:

Year:  2007        PMID: 17655493     DOI: 10.1089/hum.2006.175

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  10 in total

1.  Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors.

Authors:  Jingqiong Hu; Gabriel Renaud; Theotonius J Gomes; Theotonius Golmes; Andrea Ferris; Paul C Hendrie; Robert E Donahue; Stephen H Hughes; Tyra G Wolfsberg; David W Russell; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2008-06-24       Impact factor: 11.454

2.  Proviruses selected for high and stable expression of transduced genes accumulate in broadly transcribed genome areas.

Authors:  Jirí Plachy; Jan Kotáb; Petr Divina; Markéta Reinisová; Filip Senigl; Jirí Hejnar
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

Review 3.  Contributions of gene marking to cell and gene therapies.

Authors:  Cecilia N Barese; Cynthia E Dunbar
Journal:  Hum Gene Ther       Date:  2011-05-05       Impact factor: 5.695

Review 4.  Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.

Authors:  Chuanfeng Wu; Cynthia E Dunbar
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

5.  Self-inactivating alpharetroviral vectors with a split-packaging design.

Authors:  Julia D Suerth; Tobias Maetzig; Melanie Galla; Christopher Baum; Axel Schambach
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

6.  The core element of a CpG island protects avian sarcoma and leukosis virus-derived vectors from transcriptional silencing.

Authors:  Filip Senigl; Jirí Plachý; Jirí Hejnar
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

7.  Transgene expression facilitated by the v-src splice acceptor can impair replication kinetics and lead to genomic instability of Rous sarcoma virus-based vectors.

Authors:  Daniel Portsmouth; Daria Deitermann; Brian Salmons; Walter H Günzburg; Matthias Renner
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

Review 8.  Toward Combined Cell and Gene Therapy for Genodermatoses.

Authors:  Laura De Rosa; Maria Carmela Latella; Alessia Secone Seconetti; Cecilia Cattelani; Johann W Bauer; Sergio Bondanza; Michele De Luca
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-05-01       Impact factor: 10.005

Review 9.  Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges.

Authors:  Kristine E Yoder; Anthony J Rabe; Richard Fishel; Ross C Larue
Journal:  Front Mol Biosci       Date:  2021-05-12

Review 10.  Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy.

Authors:  Julia D Suerth; Verena Labenski; Axel Schambach
Journal:  Viruses       Date:  2014-12-05       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.